U.S. markets closed

The Cooper Companies, Inc. (COO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
96.75-1.03 (-1.05%)
At close: 04:00PM EST
96.75 0.00 (0.00%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close97.78
Bid95.18 x 800
Ask98.23 x 2900
Day's Range96.00 - 97.92
52 Week Range75.93 - 99.90
Avg. Volume1,087,155
Market Cap19.228B
Beta (5Y Monthly)0.94
PE Ratio (TTM)65.37
EPS (TTM)1.48
Earnings DateFeb 29, 2024
Forward Dividend & Yield0.02 (0.02%)
Ex-Dividend DateJul 26, 2023
1y Target Est97.79
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-36% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for COO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • The Cooper Companies, Inc.
    Analyst Report: The Cooper Companies, Inc.The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more